See Peter Wooding and his wife battle Alzheimer's, 18 months into the Aducanamab Clinical Trial. On FDA's Fast-Track program, the new vaccine's test results are stirring up significant expectations.
SOURCE:
- Time
VIDEOS & ARTICLESCare
FeaturedHealth |
|
TherapyTreatment
Types |
Comment or Share:
Post a Comment
Your comments (up to 200 words):